The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24044217 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Chiara Cencioni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of System Analysis and Informatics-National Research Council (IASI-CNR), 00185 Rome, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 330 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC.
Abstract (Originalsprache)
The concept of the Myc (c-myc, n-myc, l-myc) oncogene as a canonical, DNA-bound transcription factor has consistently changed over the past few years. Indeed, Myc controls gene expression programs at multiple levels: directly binding chromatin and recruiting transcriptional coregulators; modulating the activity of RNA polymerases (RNAPs); and drawing chromatin topology. Therefore, it is evident that Myc deregulation in cancer is a dramatic event. Glioblastoma multiforme (GBM) is the most lethal, still incurable, brain cancer in adults, and it is characterized in most cases by Myc deregulation. Metabolic rewiring typically occurs in cancer cells, and GBM undergoes profound metabolic changes to supply increased energy demand. In nontransformed cells, Myc tightly controls metabolic pathways to maintain cellular homeostasis. Consistently, in Myc-overexpressing cancer cells, including GBM cells, these highly controlled metabolic routes are affected by enhanced Myc activity and show substantial alterations. On the other hand, deregulated cancer metabolism impacts Myc expression and function, placing Myc at the intersection between metabolic pathway activation and gene expression. In this review paper, we summarize the available information on GBM metabolism with a specific focus on the control of the Myc oncogene that, in turn, rules the activation of metabolic signals, ensuring GBM growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of System Analysis and Informatics-National Research Council (IASI-CNR), 00185 Rome, Italy.
- Axxam SpA, Bresso, 20091 Milan, Italy.
- Department of Biology and Biotechnology Charles Darwin, Sapienza University, 00185 Rome, Italy.
- Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University, 00185 Rome, Italy.
- Institute of Molecular Biology and Pathology-National Research Council (IBPM-CNR), 00185 Rome, Italy.
Förderung
- AIRC
Zitieren
APA
Cencioni, C., Scagnoli, F., Spallotta, F., Nasi, S., & Illi, B. (2023). The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044217
Vancouver
Cencioni C, Scagnoli F, Spallotta F, Nasi S, Illi B. The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044217
BibTeX
@article{Cencioni2023,
author = {Cencioni, Chiara and Scagnoli, Fiorella and Spallotta, Francesco and Nasi, Sergio and Illi, Barbara},
title = {The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24044217}
}
EUVIMED